CRISPR is a technology that can be used to edit genes and, as such, will likely change the world. The essence of CRISPR is simple: it’s a way of finding a specific bit of DNA inside a cell.

CRISPR Therapeutics won its first regulatory approval a little over a year ago, and has compelling candidates in the pipeline. Of course, Vertex's success didn't happen overnight -- and the ...

CRISPR-based detection tools such as SHERLOCK ... Comparisons with existing methods highlight the accelerated timeline.

Editas Medicine struggles with underwhelming data and lacks major partnerships. Find out why EDIT stock faces significant ...

Gene editing is growing up. Ten years after Science magazine named CRISPR its 2015 “Breakthrough of the Year,” this revolutionary gene editing technology has become a workhorse of modern biology.

Different cells express different sets of genes, so if CRISPR screwed up ... or expensive, or a long timeline, get in the way,” she urged the industry representatives. “We don’t know ...

At this pre-clinical stage, AI can reduce costs, accelerate timelines, and produce more effective drug candidates.